Unique ID issued by UMIN | UMIN000048873 |
---|---|
Receipt number | R000055684 |
Scientific Title | A Mock Simulation of A Remote/Decentralised Clinical Trial for Patients with Major Depressive Disorder in Japan |
Date of disclosure of the study information | 2022/10/01 |
Last modified on | 2022/12/15 19:08:55 |
A Mock Simulation of A Remote/Decentralised Clinical Trial for Patients with Major Depressive Disorder in Japan
A Remote/Decentralised Clinical Trial Mock Simulation for Patients with Depression
A Mock Simulation of A Remote/Decentralised Clinical Trial for Patients with Major Depressive Disorder in Japan
A Remote/Decentralised Clinical Trial Mock Simulation for Patients with Depression
Japan |
Major depressive disorder
Psychiatry |
Others
NO
To identify burdens and issues of a remote/decentralised clinical trial for patients living with major depressive disorder from the viewpoints of patients, physicians, and clinical research coordinators, in order to investigate the feasibility of remote/decentralised clinical trials in patients living with major depressive disorder in the digitalisation and clinical trial environment in Japan
Others
in order to investigate the feasibility of remote/decentralised clinical trials
Patient demographics, feedback on the clinical trial plan
Observational
18 | years-old | <= |
Not applicable |
Male and Female
Inclusion criteria:
Patient:
1) A patient with a diagnosis of major depressive disorder
(according to the diagnostic criteria defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition)
2) A patient whose major depressive disorder is mild or in remission
3) A patient aged >=18 years
Investigator:
1) A physician with experience of a principal investigator conducting pharmaceutical company-sponsored clinical trials in patients with a psychiatric disorder
2) A physician with high interest in the conduct of remote/decentralised clinical trials (both as self-reported)
Person with experience of clinical research coordinator:
1) A person with experience of clinical research coordinator in a pharmaceutical company-sponsored clinical trial in patients with a psychiatric disorder
2) A person with high interest in the conduct of remote/decentralised clinical trials (both as self-reported)
Exclusion criteria:
Patient:
1) A patient not capable of providing consent to participate in this study or being interviewed at physician's discretion
20
1st name | Nobutaka |
Middle name | |
Last name | Yagi |
Nippon Boehringer Ingelheim Co., Ltd.
Patient Engagement
141-6017
2-1-1 Osaki, Shinagawa-ku,Tokyo, JAPAN
0364172043
nobutaka.yagi@boehringer-ingelheim.com
1st name | Nobutaka |
Middle name | |
Last name | Yagi |
Nippon Boehringer Ingelheim Co., Ltd.
Patient Engagement
141-6017
2-1-1 Osaki, Shinagawa-ku,Tokyo, JAPAN
0364172043
nobutaka.yagi@boehringer-ingelheim.com
Nippon Boehringer Ingelheim Co., Ltd.
Nippon Boehringer Ingelheim Co., Ltd.
Profit organization
Medical Corporation Kyoso-kai AMC Nishi-Umeda Clinic Ethics Review Committee
Maruit Nishi-Umeda Building 3F, 3-3-45 Umeda, Kita-ku, Osaka-shi, Osaka, Japan
0647975660
morikawa@amc-clinic.jp
NO
2022 | Year | 10 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2022 | Year | 08 | Month | 24 | Day |
2022 | Year | 08 | Month | 25 | Day |
2022 | Year | 12 | Month | 13 | Day |
2023 | Year | 02 | Month | 28 | Day |
Non-interventional study
2022 | Year | 09 | Month | 07 | Day |
2022 | Year | 12 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055684